Effective Immediately: OncoSec Names Former Advaxis Exec as New CEO Post author:Sam Post published:November 7, 2017 Post category:BioPharma OncoSec Medical today announced the appointment of Daniel J. O’Connor as CEO of the Company. Source: BioSpace You Might Also Like Biotech Startup Autolus Closes $80 Million for Novel Cancer Program September 25, 2017 Reminder: Centene Corporation's 2017 First Quarter Financial Results Conference Call March 14, 2017 Pliant Appoints Ph.D., As Vice President Of Chemistry And M.D., Ph.D. To The Board Of Directors September 25, 2017
Pliant Appoints Ph.D., As Vice President Of Chemistry And M.D., Ph.D. To The Board Of Directors September 25, 2017